InfuSystem (NYSEAMERICAN:INFU) Raised to “Strong-Buy” at StockNews.com

InfuSystem (NYSEAMERICAN:INFU) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Wednesday.

InfuSystem Trading Up 0.3 %

INFU stock opened at $7.92 on Wednesday. InfuSystem has a 12 month low of $7.75 and a 12 month high of $11.44. The firm has a market capitalization of $168.38 million, a P/E ratio of 264.09 and a beta of 1.24. The company has a quick ratio of 1.54, a current ratio of 1.95 and a debt-to-equity ratio of 0.56.

Hedge Funds Weigh In On InfuSystem

Several institutional investors have recently bought and sold shares of INFU. Panagora Asset Management Inc. increased its stake in InfuSystem by 1.7% in the 1st quarter. Panagora Asset Management Inc. now owns 87,948 shares of the medical instruments supplier’s stock valued at $862,000 after buying an additional 1,508 shares during the period. Rhumbline Advisers increased its stake in InfuSystem by 44.8% in the 1st quarter. Rhumbline Advisers now owns 16,232 shares of the medical instruments supplier’s stock valued at $159,000 after buying an additional 5,021 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of InfuSystem by 18.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 313,148 shares of the medical instruments supplier’s stock worth $3,069,000 after purchasing an additional 49,546 shares during the period. Vanguard Group Inc. grew its stake in shares of InfuSystem by 8.6% during the 1st quarter. Vanguard Group Inc. now owns 859,052 shares of the medical instruments supplier’s stock worth $8,418,000 after purchasing an additional 68,242 shares during the period. Finally, Wasatch Advisors Inc. grew its stake in shares of InfuSystem by 18.6% during the 1st quarter. Wasatch Advisors Inc. now owns 859,679 shares of the medical instruments supplier’s stock worth $8,425,000 after purchasing an additional 135,076 shares during the period. 71.13% of the stock is owned by institutional investors and hedge funds.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.